COSCIENS Biopharma Inc
TSX:CSCI

Watchlist Manager
COSCIENS Biopharma Inc Logo
COSCIENS Biopharma Inc
TSX:CSCI
Watchlist
Price: 2.9 CAD -2.03% Market Closed
Market Cap: 9.4m CAD

COSCIENS Biopharma Inc
Free Cash Flow

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

COSCIENS Biopharma Inc
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
COSCIENS Biopharma Inc
TSX:CSCI
Free Cash Flow
-$11m
CAGR 3-Years
5%
CAGR 5-Years
-3%
CAGR 10-Years
11%
Theratechnologies Inc
TSX:TH
Free Cash Flow
-$3.1m
CAGR 3-Years
40%
CAGR 5-Years
10%
CAGR 10-Years
-23%
Repare Therapeutics Inc
NASDAQ:RPTX
Free Cash Flow
-$70.1m
CAGR 3-Years
N/A
CAGR 5-Years
-80%
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Free Cash Flow
$119.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
X
Xenon Pharmaceuticals Inc
NASDAQ:XENE
Free Cash Flow
-$253.3m
CAGR 3-Years
-42%
CAGR 5-Years
-70%
CAGR 10-Years
-31%
Spectral Medical Inc
TSX:EDT
Free Cash Flow
-CA$9.3m
CAGR 3-Years
2%
CAGR 5-Years
-80%
CAGR 10-Years
0%
No Stocks Found

COSCIENS Biopharma Inc
Glance View

Market Cap
9.2m CAD
Industry
Biotechnology

COSCIENS Biopharma Inc is a CA-based company operating in Biotechnology industry. The company is headquartered in Toronto, Ontario. COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The firm is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.

CSCI Intrinsic Value
HIDDEN
Show

See Also

What is COSCIENS Biopharma Inc's Free Cash Flow?
Free Cash Flow
-11m USD

Based on the financial report for Sep 30, 2025, COSCIENS Biopharma Inc's Free Cash Flow amounts to -11m USD.

What is COSCIENS Biopharma Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
11%

Over the last year, the Free Cash Flow growth was 38%. The average annual Free Cash Flow growth rates for COSCIENS Biopharma Inc have been 5% over the past three years , -3% over the past five years , and 11% over the past ten years .

Back to Top